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Dual-Channel Two-Photon Microscopy Study
of Transdermal Transport in Skin Treated with
Low-Frequency Ultrasound and a Chemical Enhancer
Joseph Kushner IV1, Daekeun Kim2, Peter T.C. So2, Daniel Blankschtein1 and Robert S. Langer1
Visualization of transdermal permeant pathways is necessary to substantiate model-based conclusions drawn
using permeability data. The aim of this investigation was to visualize the transdermal delivery of
sulforhodamine B (SRB), a fluorescent hydrophilic permeant, and of rhodamine B hexyl ester (RBHE), a
fluorescent hydrophobic permeant, using dual-channel two-photon microscopy (TPM) to better understand the
transport pathways and the mechanisms of enhancement in skin treated with low-frequency ultrasound (US)
and/or a chemical enhancer (sodium lauryl sulfate – SLS) relative to untreated skin (the control). The results
demonstrate that (1) both SRB and RBHE penetrate beyond the stratum corneum and into the viable epidermis
only in discrete regions (localized transport regions – LTRs) of US treated and of US/SLS-treated skin, (2) a
chemical enhancer is required in the coupling medium during US treatment to obtain two significant levels of
increased penetration of SRB and RBHE in US-treated skin relative to untreated skin, and (3) transcellular
pathways are present in the LTRs of US treated and of US/SLS-treated skin for SRB and RBHE, and in SLS-treated
skin for SRB. In summary, the skin is greatly perturbed in the LTRs of US treated and US/SLS-treated skin with
chemical enhancers playing a significant role in US-mediated transdermal drug delivery.
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INTRODUCTION
Imaging of the skin with two-photon microscopy (TPM) has
been offered as an alternative to the use of conventional
imaging methods (e.g., scanning electron microscopy,
transmission electron microscopy, and confocal fluorescence
microscopy) for the investigation of the transdermal transport
of both hydrophilic and hydrophobic molecules. TPM is ideal
for future in vivo applications because it is a non-invasive
technique that does not damage the skin (Masters et al.,
1998), as is the case for both scanning electron microscopy
(Bommannan et al., 1992; Menon et al., 1994; Yamashita
et al., 1997; Menon and Elias, 1997) and transmission
electron microscopy (Bodde et al., 1991; Paliwal et al.,
2006). TPM also provides higher quality images at a greater
skin depth compared with confocal microscopy (Denk et al.,
1990; Diaspro, 1999; Soeller and Cannell, 1999; Paliwal
et al., 2006), because TPM involves three-body collisions
(two photons and one fluorescent molecule) to create an
excitation event, whereas confocal microscopy involves only
two-body collisions (one photon and one fluorescent
molecule), which occur with greater frequency (Denk et al.,
1990). As a result of the decreased frequency of three-body
collisions utilized by TPM, it is possible to better restrict the
imaging of fluorophores to the focal plane of interest (Masters
et al., 1997; Periasamy et al., 1999), and, therefore, increase
the discrimination of the fluorescence signal at increased
tissue depths (Denk et al., 1990). The TPM technique has
been utilized previously to examine the effect of the chemical
enhancer, oleic acid, on the transdermal transport of both a
model hydrophilic and a model hydrophobic fluorescent
probe – sulforhodamine B (SRB) and rhodamine B hexyl ester
(RBHE), respectively (see Table 1 for some relevant physical
properties of these probes) (Yu et al., 2001, 2002, 2003a, b).
In a previous investigation, analysis of skin electrical
resistivity measurements in the context of the aqueous-pore
pathway hypothesis (a theoretical model developed by our
group, which relates the permeability of a hydrophilic
permeant to the electrical resistivity of the skin through the
radii of the aqueous pore channels in the skin; Tang et al.,
2001) suggested that transcellular pathways may exist in the
stratum corneum of the highly permeable localized transport
regions (LTRs, see Figure 1 for example) that are formed in
skin treated simultaneously with the chemical enhancer,
sodium lauryl sulfate (SLS), and low-frequency ultrasound
(US), whereas intercellular pathways were suggested as the
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primary pathways in the stratum corneum of the non-LTRs
(see Figure 1) (Kushner et al., 2004). Dual-channel TPM is
performed in the current investigation to evaluate whether
transcellular or intercellular transdermal transport pathways
are utilized by SRB and RBHE in the LTRs and in the non-
LTRs of skin treated simultaneously with low-frequency US
and SLS as well as in the LTRs and in the non-LTRs of
US-treated skin, and SLS-treated skin relative to untreated
skin (the control) (see Results and Discussion). Dual-channel
TPM allows for simultaneous imaging of the exogenous
fluorescent permeant (i.e., SRB or RBHE) and the intrinsic
skin fluorophores (i.e., collagen, elastin, aromatic amino
acids, nicotinamide adenine dinucleotide, porphyrins, and
flavin adenine dinucleotide; Na et al., 2000, 2001). This
method allows the location of SRB or RBHE to be determined
relative to the structure of the skin, making it possible to
examine whether SRB or RBHE penetrates the corneocyte
domain or remains in the intercellular domain (see Materials
and Methods). In addition to evaluating the presence of
transcellular and intercellular transdermal pathways in each
of the six skin types examined in the current investigation,
profiles of the average fluorescence intensity of SRB and
RBHE as a function of skin depth are generated from the dual-
channel TPM images to identify significant differences in the
extent and the depth of the penetration of SRB and RBHE as
well as to evaluate enhancement in the values of the vehicle-
to-skin partition coefficient (K), the fluorescent intensity
gradient (dI/dz), and the effective diffusion path length (L)
relative to untreated skin (see Results and Discussion).
RESULTS
Qualitative analysis of the dual-channel TPM images
Figures 2 and 3 show samples of the 120120 mm dual-
channel TPM images obtained for the delivery of the
fluorescent permeants, SRB and RBHE, respectively, in each
of the six types of skin samples examined in this study: (1)
untreated skin, (2) SLS-treated skin, (3) the non-LTRs of US-
treated skin, (4) the LTRs of US-treated skin, (5) the non-LTRs
of US/SLS-treated skin, and (6) the LTRs of US/SLS-treated
skin. In Figures 2 and 3, the red channel images show the
locations of SRB and RBHE in the skin, respectively, and the
green channel images show the location of the intrinsic skin
fluorophores. The vertical intensity scale bar adjacent to each
image ranges from values corresponding to high fluorescence
intensities (bright red for SRB and RBHE, and bright green for
the skin autofluorescence) to values corresponding to no
fluorescence intensities (black for both the exogenous probes
and the skin autofluorescence). Sample dual-channel TPM
images are presented at z¼0 mm (the skin surface),
z¼10 mm, and z¼ 40 mm to provide qualitative information
on how the amount and locations of SRB and RBHE change
as a function of skin depth in each of the six skin sample types
considered. Where appropriate, the location of a representa-
tive corneocyte in the stratum corneum has been indicated
with a ‘‘C’’, and the visualization of the stratum spinosum (SS)
layer of the viable epidermis has been indicated with a ‘‘SS’’.
Horizontal white scale bars, representing a length of 24 mm,
have been included to aid the reader in approximating
dimensions. As a control, untreated skin and US/SLS-treated
skin imaged using dual-channel TPM in the absence of SRB
or RBHE (a negative control) are presented in Figure 4,
showing the expected results of the skin structure in the green
channel image, obtained from the intrinsic skin fluorophores,
and no corresponding image in the red channel because no
exogenous fluorophores were included in the coupling
medium for these skin samples.
Average fluorescence intensity profiles of SRB and RBHE
Figures 5 and 6 show the average fluorescence intensity
profiles of SRB and RBHE, respectively, obtained from the red
channel TPM images. In each figure, the average fluores-
cence intensity of each permeant is plotted on the y axis and
Table 1. Relevant physical properties of the
fluorescent hydrophilic probe, SRB, and of the
fluorescent hydrophobic probe, RBHE, examined with
two-photon microscopy (Yu et al., 2001)
Probe
Molecular weight
(Da)
Absorbance/emission
(nm)1 Log KO/PBS
2
SRB 559 565/586 0.4570.0045
RBHE 627 556/578 2.4970.18
rhodamine B hexyl ester, RBHE; sulforhodamine B, SRB.
1Fluorescence absorbance and emission wavelengths of SRB and RBHE.
2Octanol – phosphate-buffered saline partition coefficient.
LTRs
Non-LTRs
Figure 1. Sample macroscopic image of the LTRs and of the surrounding
regions of the skin (the non-LTRs), as indicated by the black arrows. LTRs are
formed in skin treated with US in the presence of a red fluorescent permeant
(Kushner et al., 2004). Bar¼5 mm.
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the depth (z) from the skin surface (at z¼0 mm), in mm, is
plotted on the x axis. The error bars represent one standard
deviation (SD) in the average value of the permeant
fluorescence intensity (for clarity, only the upper error bars
are shown in Figures 5 and 6). In addition, the results of the
statistical analysis of the fluorescence intensity profiles of
each permeant are also shown in Figures 2 and 3.
Specifically, a bar (solid or dashed) with a single asterisk (*)
indicates the range over which the average fluorescence
intensity values from the enhanced skin sample are statisti-
cally different (Po0.05) from the average fluorescence
intensity values from the untreated skin samples. A solid
bar with a double asterisk (**) indicates the range over which
the average fluorescence intensity values of the LTRs is
statistically different (Po0.05) from the average fluorescence
intensity values of the non-LTRs.
Enhancements in the vehicle-to-skin partition coefficient, the
intensity gradient, and the effective diffusion path length for
SRB and for RBHE
Tables 2 and 3 report values of the average fluorescence
intensity at the skin surface, I(z¼0), and of the intensity
Red channel – SRB fluorescence
Green channel – skin autofluorescence
Untreated
z = 0
z = 10
z = 40
z = 0
z = 10
z = 40
SLS-treated
US-treated
non-LTRs
US-treated
LTRs
US/SLS-treated
non-LTRs
US/SLS-treated
LTRs
Skin
depth
(m)
Figure 2. Dual-channel TPM images of SRB in each of the six types of skin samples examined as a function of skin depth (z). C, representative corneocyte; SS,
stratum spinosum; horizontal white scale bar, 24mm. Each image is 120 120mm. The vertical intensity scale bar adjacent to each image ranges from high
fluorescent intensities (bright red for SRB and bright green for the skin autofluorescence) to no fluorescence intensity (black for both the red and the green
channels.
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gradient, dI/dz, as well as the values of the enhancement in
the vehicle-to-skin partition coefficient, EK, the enhancement
in the intensity gradient, EG, and the enhancement in the
effective diffusion path length, EL, for the delivery of SRB and
RBHE, respectively, in each of the five types of enhanced skin
samples examined in this study – SLS-treated skin, the non-
LTRs and the LTRs of US-treated skin, and the non-LTRs and
the LTRs of US/SLS-treated skin. The errors reported for I(z¼0),
dI/dz, EK, EG, and EL are presented as71 SD. Values of I(z¼0)
and dI/dz corresponding to the enhanced skin samples
presented in bold are significantly different (Po0.05) from
the values of I(z¼0) and dI/dz corresponding to the untreated
skin samples.
Investigation of the existence of transcellular permeation
pathways in the stratum corneum
Figure 7a and b show a sample plot of the normalized
average fluorescence intensity (plotted on the y axis) across a
five pixelwide slice of the dual-channel TPM image for the
delivery of SRB and RBHE, respectively, in the six types of
skin samples examined (note that a plot for the delivery of
SRB and RBHE in untreated skin was selected for illustrative
purposes), as a function of the length of the slice, ranging in
value from 0 to 255 pixels (plotted on the x axis). The red and
the green curves in Figure 7 correspond to the normalized
average SRB fluorescence intensity curve and to the normal-
ized average fluorescence intensity curve of the skin
Red channel – RBHE fluorescence
Green channel – skin autofluorescence
Untreated
z = 0
z = 10
z = 40
z = 0
z = 10
z = 40
SLS-treated
US-treated
non-LTRs
US-treated
LTRs
US/SLS-treated
non-LTRs
US/SLS-treated
LTRs
Skin
depth
(m)
Figure 3. Dual-channel TPM images of RBHE in each of the six types of skin samples examined as a function of skin depth (z). C, representative
corneocyte; SS, stratum spinosum; horizontal white scale bar, 24 mm. Each image is 120 120mm. The vertical intensity scale bar adjacent to
each image ranges from high fluorescent intensities (bright red for RBHE and bright green for the skin autofluorescence) to no fluorescence
intensity (black for both the red and the green channels.
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autofluorescence, respectively. The various vertical arrows
have been included to assist in identifying the peaks in the
green curves, which denote the location of the intercellular
regions of the stratum corneum. Table 4 reports the measured
values of the average heights and of the average widths of the
peaks in the red curves at the skin surface (z¼0 mm),
corresponding to the delivery of SRB (Figure 7a) and of
RBHE (Figure 7b), in each of the six types of skin samples
examined. Table 5 reports similar values at a depth of
z¼3 mm for the skin samples that have significant transcel-
lular penetration at the skin surface (z¼ 0mm). In Tables 4
and 5, the values are reported as the average measurements,
71 SD, of the heights and the widths of 3–5 peaks. Values of
peak widths and peak heights shown in bold are significantly
Untreated skin
Red channel Green channel Red channel Green channel
z = 5 m
z = 10 m
US/SLS-treated skin
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Figure 4. Dual-channel TPM images in the absence of exogenous fluorescent permeant in untreated skin and in US/SLS-treated skin at depths of
5 and 10 lm. C, representative corneocyte; horizontal white scale bar, 24 mm. Each image is 120120 mm. The vertical intensity scale bar adjacent
to each image ranges from high fluorescent intensities (bright red for exogenous permeant and bright green for the skin autofluorescence)
to no fluorescence intensity (black for both the red and the green channels).
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Figure 5. SRB average fluorescence intensity profiles as a function of skin depth (z) from the skin surface (at z¼ 0 lm). (a) SLS-treated skin versus
untreated skin, (b) the non-LTRs and the LTRs of US-treated skin versus untreated skin, and (c) the non-LTRs and the LTRs of US/SLS-treated skin versus
untreated skin. Black diamonds, untreated skin samples; open diamonds, SLS-treated skin samples; open triangles, the non-LTRs; open circles, the LTRs.
Error bars represent 1 SD in the average value of 5–7 skin samples. For clarity, only the upper error bars are shown. Single asterisks (*) indicate regions
of significant difference (Po0.05) between SRB delivery in enhanced skin and in untreated skin. Double asterisks (**) indicate regions of significant
difference (Po0.05) between SRB delivery in the non-LTRs and in the LTRs. (c) The dashed line with the single asterisk (*) corresponds to the confidence
interval for the non-LTRs.
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different (Po0.05) from the values of peak widths and peak
heights corresponding to the delivery of SRB and RBHE in
untreated skin.
DISCUSSION
Qualitative analysis of the dual-channel TPM images
On the basis of dual-channel TPM images presented in
Figures 2 and 3, three qualitative statements can be made
regarding the delivery of SRB and RBHE in the six skin sample
types considered. First, more SRB and RBHE penetrate into
the corneocytes at the surface (see z¼ 0 mm for the red
channel in Figures 2 and 3) of the LTRs in both US-treated
and US/SLS-treated skin (both for SRB and RBHE) as well as
for SRB delivery in SLS-treated skin, compared to untreated
skin. This statement is based on the observed uniform
distribution of SRB and RBHE between the intercellular and
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Figure 6. RBHE average fluorescence intensity profiles as a function of skin depth (z) from the skin surface (at z¼ 0 lm). (a) SLS-treated skin versus untreated
skin, (b) the non-LTRs and the LTRs of US-treated skin versus untreated skin, and (c) the non-LTRs and the LTRs of US/SLS-treated skin versus untreated skin.
Black diamonds, untreated skin samples; open diamonds, SLS-treated skin samples; open triangles, the non-LTRs; open circles, the LTRs. Error bars represent
1 SD in the average value of 5–7 skin samples. For clarity, only the upper error bars are shown. Single asterisks (*) indicate regions of significant difference
(Po0.05) between RBHE delivery in enhanced skin and in untreated skin. Double asterisks (**) indicate regions of significant difference (Po0.05) between
RBHE delivery in the non-LTRs and in the LTRs. (b and c) The dashed lines with the single asterisks (*) correspond to the confidence intervals for the non-LTRs.
Table 2. Calculated values of the vehicle-to-skin partition coefficient enhancement, EK, the intensity gradient
enhancement, EG, and the effective diffusion path length enhancement, EL, for the delivery of SRB in each of the five
types of enhanced skin samples examined obtained from the values of the average fluorescence intensity at the skin
surface I(z¼ 0), and of the intensity gradient, dI/dz
1,2,3
Skin type Iz=0 dI/dz EK EG EL
Untreated 2.4271.52 0.15770.004 — — —
SLS-treated 5.6773.04 0.42670.020 2.3471.93 2.7870.14 0.8470.70
US-treated (non-LTRs) 3.2871.88 0.13570.005 1.3571.15 0.8670.04 1.5871.25
US-treated (LTRs) 10.473.08 0.43970.015 4.3272.99 2.7970.12 1.5571.00
US/SLS-treated (non-LTRs) 8.9272.39 0.63270.012 3.6972.51 4.0270.13 0.9270.37
US/SLS-treated (LTRs) 15.473.05 0.82770.037 6.3674.18 5.2670.27 1.2170.41
LTR, localized transport regions; SLS, sodium lauryl sulfate; SRB, sulforhodamine B; US, ultrasound.
1EK, EG, and EL were calculated using equations (1)–(3) (see Materials and Methods).
2The errors in I(z¼0), dI/dz, EK, EG, and EL are 1 SD.
3Values of I(z¼ 0) and dI/dz corresponding to enhanced skin samples presented in bold are significantly different (Po0.05) from the values of I(z¼0) and dI/dz
corresponding to untreated skin samples.
www.jidonline.org 2837
J Kushner et al.
TPM Investigation of Transdermal Transport
corneocyte domains in the red channel image in the five
skin samples identified above relative to untreated skin,
where both SRB and RBHE appear to be localized primarily
in the intercellular domain. Second, as the depth is increased
from z¼0 to z¼10 mm, the shapes of the corneocytes in
the red channel images of SRB and RBHE become more
distinct in the five skin samples identified above, indicating
that less SRB and RBHE penetrate into the corneocytes in the
deeper layers of the stratum corneum in the LTRs of
US-treated and US/SLS-treated skin as well as for SRB
delivery in SLS-treated skin, relative to the penetration into
the corneocytes at the surface of these five skin samples.
Third, changes in the structure of the skin in the LTRs of
US-treated and US/SLS-treated skin are observed from z¼ 0
to z¼10 mm, where the corneocytes of the stratum corneum
(diameter: 30–40 mm) are observed in both the red and
the green channels, to z¼40 mm, where a smaller pattern of
dots (diameter: 2–3 mm) is observed in both the red and the
green channels. These dots have similar dimensions to the
nuclei of cells located in the SS layer of the viable epidermis
(Montaga et al., 1992), suggesting that SRB and RBHE
penetrate into the viable epidermis in the LTRs of both
US-treated and US/SLS-treated skin. For the remaining skin
samples, there is either no significant SRB and RBHE
penetration at z¼40 mm (see untreated and SLS-treated
skin for SRB and the non-LTRs for both US-treated and
US/SLS-treated skin for both SRB and RBHE) or the presence
of the corneocytes (see untreated and SLS-treated skin for
RBHE), suggesting that the penetration of SRB and RBHE is
restricted to the stratum corneum.
Analysis of the average fluorescence intensity profiles of SRB
In Figure 5a, the SRB average intensity profile in SLS-
enhanced skin (open diamonds) is compared to the SRB
average intensity profile in untreated skin (black diamonds).
As indicated by the solid bar with a single asterisk (*) in
Figure 5a, there is a significant increase (Po0.05) in the
average intensity of SRB in the first 14 mm of the SLS-treated
skin as compared with the average intensity of SRB in the first
14 mm of the untreated skin. In addition, the SRB average
fluorescence intensity decreases to near zero values over the
first 20 mm of both SLS treated and untreated skin, indicating
Table 3. Calculated values of the vehicle-to-skin partition coefficient enhancement, EK, the intensity gradient
enhancement, EG, and the effective diffusion path length enhancement, EL, for the delivery of RBHE in each of the
five types of enhanced skin samples examined obtained from the values of the average fluorescence intensity at the
skin surface I(z¼ 0), and of the intensity gradient, dI/dz
1,2,3
Skin type I(z=0) dI/dz EK EG EL
Untreated 5.7372.74 0.20770.034 — — —
SLS treated 7.0471.34 0.27970.018 1.2370.63 1.3570.24 0.9170.49
US treated (non-LTRs) 186733 11.7170.35 32.5716.6 56.679.5 0.5770.31
US treated (LTRs) 4737136 16.3270.51 82.5746.0 78.8713.3 1.0570.61
US/SLS treated (non-LTRs) 189752 16.2571.61 33.0718.2 78.5715.1 0.4270.25
US/SLS treated (LTRs) 199748 12.5770.95 34.9718.7 60.7711.0 0.5770.32
LTR, localized transport regions; rhodamine B hexyl ester, RBHE; SLS, sodium lauryl sulfate; US, ultrasound.
1EK, EG, and EL were calculated using equations (1)–(3) (see Materials and Methods).
2The errors in I(z¼0), dI/dz, EK, EG, and EL are 1 SD.
3Values of I(z¼ 0) and dI/dz corresponding to enhanced skin samples presented in bold are significantly different (Po0.05) from the values of I(z¼0) and dI/dz
corresponding to untreated skin samples.
N
or
m
al
iz
ed
 a
ve
ra
ge
 fl
uo
re
sc
en
ce
 
in
te
ns
ity
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0 50 100
Pixel number
150 200 250
N
or
m
al
iz
ed
 a
ve
ra
ge
 fl
uo
re
sc
en
ce
 
in
te
ns
ity
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0 50 100
Pixel number
150 200 250
a
b
Figure 7. Normalized fluorescent probe and skin autofluorescence
intensities in untreated skin. Autofluorescence intensities (y axis) are
expressed as a function of the pixel number along the length of the image
slice (x axis). (a) SRB and (b) RBHE. Red, fluorescent probe; green, skin
autofluorescence; vertical arrows, location of intercellular region.
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that the stratum corneum (whose thickness is typically of the
order of 20 mm (Schaefer and Redelmeier, 1996)) provides the
primary barrier to the delivery of SRB in SLS-treated skin,
similar to untreated skin. Furthermore, there is little penetra-
tion of SRB into the skin deeper than 20 mm in both SLS-
treated skin and in untreated skin, confirming that SRB
penetration is confined solely to the stratum corneum in SLS
treated and in untreated skin.
In Figure 5b and c, the SRB average intensity profiles of the
non-LTRs (open triangles) and of the LTRs (open circles) in
US-treated and in US/SLS-treated skin are compared with the
SRB average intensity profile in untreated skin (black
diamonds), respectively. The average intensity of SRB within
the LTRs of US-treated and of US/SLS-treated skin is
significantly greater (Po0.05) than the average intensity of
SRB within both untreated skin (as shown by the solid bars
with a single asterisk (*)) and the non-LTRs of US-treated and
of US/SLS-treated skin (as shown by the solid bars with a
double asterisk (**)) over the depth of skin imaged in Figure
5b and c. However, the intensity of SRB in the non-LTRs is
only significantly greater (Po0.05) than that of untreated skin
in the first 21mm of US/SLS-treated skin (as shown by the
dashed bar with a single asterisk (*) in Figure 5). Furthermore,
the average intensity of SRB in the non-LTRs of both US-
treated and US/SLS-treated skin decreases rapidly toward
near zero intensity in the first 20–30 mm from the skin surface
(see Figure 5b and c, respectively). These results confirm that
the extent and the depth of SRB penetration into the LTRs of
US-treated and of US/SLS-treated skin are greater than the
extent and the depth of SRB penetration in both untreated
skin and the non-LTRs of US-treated and of US/SLS-treated
skin, whereas significant penetration of SRB in the non-LTRs
of US-treated and US/SLS-treated skin is restricted to the
stratum corneum. As no enhancement of the non-LTRs was
Table 4. Measured values of the normalized average peak heights and of the average peak widths1 for the delivery
of SRB and RBHE at the surface (z¼ 0 lm) in each of the six types of skin samples examined2,3
SRB RBHE
Skin type Height4 Width5 Height4 Width5
Untreated 0.6170.07 1773 0.6570.15 1475
SLS-treated 0.4670.07 3076 0.8270.09 871
US-treated (non-LTRs) 0.7970.16 1675 0.6870.24 25715
US-treated (LTRs) 0.2570.11 3874 No discernible peaks
US/SLS-treated (non-LTRs) 0.5370.12 1775 0.6570.28 23711
US/SLS-treated (LTRs) 0.2470.05 2175 0.5870.14 3079
LTR, localized transport regions; RBHE, rhodamine B hexyl ester; SLS, sodium lauryl sulfate; SRB, sulforhodamine B; US, ultrasound.
1The peak width was evaluated at half of the height of the peaks.
2The errors are presented as 1 SD in the average.
3Values in bold are significantly different (Po0.05) from the values for untreated skin.
4The height is presented as a dimensionless quantity, normalized by the maximum value of the fluorescent permeant intensity at z¼ 0 mm.
5The width is presented in units of pixels.
Table 5. Measured values of the average peak height and of the average peak width1 for the delivery of SRB and
RBHE at z¼ 3 lm in skin samples exhibiting significant probe penetration at the skin surface2,3
SRB RBHE
Skin type Height4 Width5 Height4 Width5
Untreated skin 0.6170.06 1572 0.6970.09 1375
SLS-treated 0.3670.13 3072 No entry at z¼ 0 lm
US-treated (LTRs) 0.4470.09 3775 0.2770.09 38725
US/SLS-treated (LTRs) 0.6070.12 2575 0.4570.196 24714
LTR, localized transport regions; RBHE, rhodamine B hexyl ester; SLS, sodium lauryl sulfate; SRB, sulforhodamine B; US, ultrasound.
1The peak width was evaluated at half of the height of the peaks.
2The errors are presented as 1 SD in the average.
3Values in bold are significantly different (Po0.05) from the values for untreated skin.
4The height is presented as a dimensionless quantity.
5The width is presented in units of pixels.
6A statistical difference in the height of the RBHE peaks in the LTRs of US/SLS-treated skin and of untreated skin exists at a level of Po0.10, corresponding to
a 90% confidence interval.
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observed in US-treated skin, this result suggests that US only
perturbs discrete regions of the skin to enhance the
transdermal penetration of model permeants, which is
consistent with previous studies examining the penetration
of hydrophilic fluorescent permeants in US-treated skin
(Alvarez-Roma´n et al., 2003). Finally, although the presence
of a chemical enhancer (i.e., SLS) during US treatment is not
required for the formation and the enhancement of the LTRs,
it is necessary to achieve enhancement of the non-LTRs and
to create two significant levels of enhancement in skin treated
with US. This result independently confirms the presence of
two levels of enhancement, as determined recently using
calcein permeability and skin electrical resistivity measure-
ments, in skin treated simultaneously with US and SLS
(Kushner et al., 2004).
Analysis of the average fluorescence intensity profiles of RBHE
In Figure 6a, the RBHE average intensity profile in SLS-
enhanced skin (open diamonds) is compared with the RBHE
average intensity profile in untreated skin (black diamonds).
There is a significant increase (Po0.05) in the average
intensity of RBHE in the first 40 mm of SLS-treated skin below
the skin surface (at z¼ 0 mm) compared with the average
intensity of RBHE in the first 40 mm of untreated skin below
the skin surface (see the solid bar with a single asterisk (*) in
Figure 6a). The RBHE average intensity profiles for the SLS-
treated skin and for the untreated skin both decrease toward
zero intensity in the region in which the stratum corneum is
present. Recall that, for RBHE delivery in untreated and in
SLS-treated skin, the stratum corneum was observed down to
a depth of 40 mm (see the green channel images for untreated
and for SLS-treated skin in Figure 3), indicating the existence
of a thicker than normal stratum corneum in these skin
samples. Therefore, this result suggests that RBHE penetration
is confined solely to the stratum corneum in both SLS treated
and in untreated skin, similar to the case of SRB delivery in
SLS treated and in untreated skin discussed above.
In Figure 6b and c, the RBHE average intensity profiles of
the non-LTRs (open triangles) and of the LTRs (open circles) in
US-treated and in US/SLS-treated skin are compared,
respectively, to the RBHE average intensity profile in
untreated skin (black diamonds). In Figure 6b, the average
intensity of RBHE in the non-LTRs and in the LTRs of US-
treated skin is significantly (Po0.05) greater than the average
intensity of RBHE in untreated skin, over the entire depth of
skin imaged (see the dashed and the solid bars with a single
asterisk (*)). In Figure 6c, the average intensity of RBHE in US/
SLS-treated skin is significantly (Po0.05) greater than the
average intensity of RBHE in untreated skin in the first 21 mm
for the non-LTRs of US/SLS-treated skin (see the dashed bar
with a single asterisk (*)) and over the entire depth of skin
imaged for the LTRs of US/SLS-treated skin (see the solid bar
with a single asterisk (*)). These results indicate that more
RBHE penetrates into the skin within both the non-LTRs and
the LTRs of both US- and US/SLS-treated skin relative to
untreated skin. In addition, the average intensity of RBHE in
the non-LTRs of both US-treated and US/SLS-treated skin
decreases rapidly toward near zero intensity in the first
20–30 mm, the region where the stratum corneum is located,
whereas the average intensity of RBHE in the LTRs of both
US-treated and US/SLS-treated skin maintains a high value at
depths greater than 30 mm. This result suggests that RBHE
penetration into the non-LTRs of US/SLS-treated skin is
confined solely to the stratum corneum, while RBHE
penetration into the LTRs of both US-treated and US/SLS-
treated skin extends into the viable epidermis. Finally,
because the intensity of RBHE in the LTRs is significantly
(Po0.05) greater than the intensity of RBHE in the non-LTRs
over the entire depth of US-treated skin imaged and at depths
greater than 4 mm in US/SLS-treated skin (see the solid bar
with a double asterisk (**) in Figures 3c and 6b, respectively),
one may conclude that two levels of skin perturbation also
take place for the delivery of RBHE in both US-treated and
US/SLS-treated skin, similar to the case of SRB delivery in US/
SLS-treated skin.
Effect of changes in the skin morphology and barrier properties
on the shape of the probe average fluorescence intensity
profiles within the LTRs of US-treated and of US/SLS-treated
skin
In Figures 5b, 5c, 6b, and 6c, after an initial linear decrease of
the average fluorescence intensity profiles in the LTRs in the
region of the skin corresponding to the stratum corneum
(z¼0 to z¼ 15–20 mm), the average fluorescence intensity
increases as the skin depth (z) increases in the upper layers of
the viable epidermis. Because the average fluorescence
intensity is proportional to the total amount of SRB or RBHE
present in each layer of the skin, the observed increase in the
average fluorescence intensity profiles in the LTRs in the
upper layers of the viable epidermis indicates that the total
amount of SRB or RBHE in each layer increases as a function
of skin depth over this range. According to the principles of
diffusive transport, the concentration of SRB or RBHE in each
layer must decrease as a function of depth in the upper layers
of the viable epidermis to maintain the flux of SRB or RBHE
through the skin. The concentration of SRB or RBHE in each
imaged skin layer is defined as the total amount of SRB or
RBHE divided by the volume of the imaged skin layer
available to SRB or RBHE transport. Since concentration must
decrease and the average fluorescence intensity profiles in
the LTRs are observed to increase in the upper layers of the
viable epidermis, the volume of the imaged skin layer
available to transport must increase by more than the total
amount of SRB or RBHE increases over the same range. Since
the thickness of the focal plane does not increase with
imaging depth, only the cross-sectional area of the imaged
layer of skin available to transport can increase in the upper
layers of the epidermis.
The upper layers of the viable epidermis comprise the
stratum granulosum, which serves as a transitional layer
between the stratum corneum and the SS of the viable
epidermis (Schaefer and Redelmeier, 1996). As one moves
from the stratum corneum through the stratum granulosum to
the SS, the diameter of the skin cells gradually decreases from
a diameter of 40 mm in the stratum corneum (Johnson et al.,
1997) to a diameter of 10–12 mm in the viable epidermis
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(Schaefer and Redelmeier, 1996), which results in a gradual
increase in the fraction of the skin occupied by the
intercellular domain from 8–9% in the stratum corneum
(Johnson et al., 1997) to 15% in the viable epidermis
(Schaefer and Redelmeier, 1996). In addition, the barrier
properties of the skin cells decrease as one moves from the
stratum corneum through the stratum granulosum to the SS.
The formation of the cornified envelope, a highly cross-linked
network of covalently bound proteins and lipids that
surrounds the corneocytes of the stratum corneum and is
responsible for providing the cell membrane resistance to
permeant transport, begins in the upper layers of the SS and
continues to develop in the stratum granulosum (Schaefer and
Redelmeier, 1996). Therefore, as one moves from the stratum
corneum through the stratum granulosum to the SS, SRB and
RBHE can more easily penetrate inside the skin cells
(compare the red channel images at z¼ 10 mm and z¼40 mm
for the LTRs in both US-treated and US/SLS-treated skin in
Figures 2 and 3). Both of these effects – decreased cell
diameter and reduced barrier properties – lead to an increase
in the cross-sectional area available to transport as a function
of skin depth in the stratum granulosum.
It is noteworthy that the shapes of the average fluores-
cence intensity profiles in the LTRs are not dependent on the
presence of SLS during US treatment or on the physicochem-
ical properties of SRB and RBHE. It should also be noted that
the increase in the average intensity of SRB and RBHE in the
upper layers of the viable epidermis is less pronounced in
Figures 5b and 6b than in Figures 5c and 6c. Recall that for
the case of US treatment, the skin is exposed to SRB and
RBHE for 24 hours before imaging, whereas for the case of
US/SLS treatment, the skin is exposed to SRB and RBHE for
only 5–10 minutes before imaging (see Materials and Meth-
ods). Therefore, for the US-treated skin experiments, SRB and
RBHE have more time to fully penetrate into the lower layers
of the stratum corneum (compare the red channel images for
z¼10 mm in the LTRs of US-treated skin with the LTRs of US/
SLS-treated skin in Figures 2 and 3) and in the upper layers of
the viable epidermis, allowing for a more uniform distribution
of SRB and RBHE in these skin layers as a function of skin
depth.
Analysis of the enhancements in the vehicle-to-skin partition
coefficient, the intensity gradient, and the effective diffusion
path length for SRB and for RBHE
A significant increase (Po0.05) in the magnitudes of I(z¼0)
and dI/dz relative to untreated skin are observed in SLS-
treated skin, the LTRs of US-treated skin, and the non-LTRs
and the LTRs of US/SLS-treated skin for the delivery of SRB
(see Table 2), and in both, the non-LTRs and the LTRs of
US-treated and US/SLS-treated skin, for the delivery of RBHE
(see Table 3). The corresponding values for EK and EG in these
skin samples are all much larger than unity (see Tables 2 and
3), although this trend is not observed for the values of EL
calculated using equation (3) (see Materials and Methods),
suggesting that there is no significant alteration of the
effective diffusion path used by SRB and RBHE in these skin
samples. Also, because the values of EL are small compared
to the values of EG, the observed enhancement in the
intensity gradient in these skin samples is primarily due to an
enhancement in the value of I(z¼0) from SLS and/or US
treatment of the skin. However, for the delivery of SRB in the
non-LTRs of US-treated skin, because there is only a small
significant decrease (Po0.05) in the magnitude of dI/dz and
no significant difference in the value of I(z¼ 0) relative to
untreated skin, the corresponding values of EK, EG, and EL are
not very different from unity, suggesting that delivery of SRB
in the non-LTRs of US-treated skin is similar to the delivery of
SRB in untreated skin. Similarly, for the delivery of RBHE in
SLS-treated skin, because there is only a small significant
increase (Po0.05) in the magnitude of dI/dz and no
significant difference in the value of I(z¼0) relative to
untreated skin, the corresponding values of EK, EG, and EL
are once again not very different from unity, suggesting that
the delivery of RBHE in SLS-treated skin is similar to the
delivery of RBHE in untreated skin. Finally, for the delivery of
SRB, the values of I(z¼ 0) and dI/dz corresponding to the non-
LTRs in US/SLS-treated skin are both significantly different
(Po0.05) than the values of I(z¼ 0) and dI/dz corresponding to
the LTRs in US/SLS-treated skin, further confirming the
existence of two levels of perturbation in skin treated
simultaneously with US and the chemical enhancer, SLS.
However, for the delivery of RBHE, the values of both I(z¼0)
and dI/dz are significantly different (P40.05) for the LTRs
relative to the non-LTRs in both US-treated and US/SLS-
treated skin. This result further confirms that, contrary to the
case of SRB delivery, two levels of skin perturbation are
present in both US-treated and US/SLS-treated skin for the
delivery of RBHE.
Impact of ethanol, a chemical enhancer, on the delivery of
RBHE
From a comparison of the results for the delivery of SRB and
RBHE reported in the previous sections, there are two cases
where the results for SRB and RBHE differ: (i) SLS-treated skin
relative to untreated skin and (ii) the non-LTRs of US-treated
skin relative to untreated skin. The observed differences can
be attributed to the presence of ethanol in the RBHE donor
solution, which was required to solubilize RBHE, a hydro-
phobic permeant, in phosphate-buffered saline (PBS) (see
Materials and Methods). Ethanol, however, can serve as a
chemical enhancer for the transdermal delivery of both
hydrophobic permeants (Femenia-Fonta et al., 2005; Johnson
et al., 1996; Bhatia et al., 1997; Magnusson and Runn, 1999;
Pillai et al., 2004) and hydrophilic permeants (Peck et al.,
1994). Noting that ethanol was present at a concentration of
50% (v/v), whereas SLS was present only at a concentration of
1% (w/v), the enhancing effect of SLS on the transdermal
delivery of RBHE is expected to be small relative to that of
ethanol. Indeed, there was only a 23% increase in the surface
concentration of RBHE and a 35% increase in the intensity
gradient of RBHE after a 24 hours treatment with 1% SLS
relative to untreated skin. This result is similar to the
70–140% enhancement in the permeability of mannitol in
50:50 mixture of ethanol and PBS after a 40 hours treatment
with 1% SLS (Karande and Mitragotri, 2002) relative to
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untreated skin. Furthermore, the presence of ethanol in the
RBHE coupling medium during US treatment can also
explain the increased penetration of RBHE into the non-LTRs
of US-treated skin relative to untreated skin, similar to the
observation for the delivery of SRB in skin treated simulta-
neously with US and with a chemical enhancer, SLS.
Therefore, ethanol also acts as a chemical enhancer to create
two levels of perturbation for the case of RBHE delivery in
US-treated skin.
Analysis of transcellular permeation pathways in the stratum
corneum
For the delivery of SRB in SLS-treated skin, the penetration of
SRB into the corneocytes located at z¼0 mm in these skin
samples increases relative to untreated skin, because the
average widths of the SRB peaks are significantly larger
(Po0.05) and the average heights of the SRB peaks are
significantly smaller (Po0.05) than the corresponding fluor-
escence peaks for untreated skin reported in Table 4.
However, for the delivery of RBHE in SLS-treated skin, the
penetration of RBHE into the corneocytes located at the
surface of SLS-treated skin decreases relative to untreated
skin, because the average widths of the RBHE fluorescence
peaks in SLS-treated skin are significantly smaller (Po0.05)
and the average heights of the RBHE fluorescence peaks are
approximately 20% larger than the corresponding RBHE
peaks in untreated skin reported in Table 4. These results
suggest that SLS increases the partitioning of SRB, a
hydrophilic permeant, into the corneocyte domain (a hydro-
philic environment) while it localizes RBHE within the
intercellular lipid domain of the stratum corneum (a
hydrophobic environment). These findings are consistent
with previous studies on the role of the chemical enhancer,
oleic acid, on the transdermal delivery of SRB and RBHE (Yu
et al., 2003b).
For the delivery of SRB and RBHE in the non-LTRs of
US-treated skin and of US/SLS-treated skin, there is no
significant difference (P40.05) in the heights and the widths
of the fluorescence peaks when compared to the heights and
the widths of the SRB fluorescence peaks in untreated skin
(see Table 4). This data provides further evidence that the
delivery of SRB and RBHE in the non-LTRs in both US-treated
and US/SLS-treated skin occurs primarily via the intercellular
route, similar to what occurs in untreated skin. For the case of
RBHE delivery in the LTRs of US-treated skin, there are no
discernable peaks present (data not shown), due to the
uniform distribution of RBHE in the corneocytes and in the
intercellular regions. Therefore, no peak widths or peak
heights are reported in Table 4. For the delivery of SRB in
SLS-treated skin and in the LTRs of US-treated skin and of US/
SLS-treated skin, and for the delivery of RBHE in the LTRs of
US/SLS-treated skin, the penetration of SRB and RBHE into
the corneocytes located at z¼0 mm in these skin samples
increases relative to untreated skin, because the average
widths of the fluorescence peaks are significantly larger
(Po0.05) and the average heights of the fluorescence peaks
are significantly smaller (Po0.05) than the corresponding
fluorescence peaks for untreated skin reported in Table 4.
Furthermore, increased penetration of both SRB and RBHE
into the corneocytes of the LTRs of US-treated and US/SLS-
treated skin, as well as of SRB into the corneocytes of SLS-
treated skin, is also observed at a depth of z¼ 3 mm relative to
untreated skin (see Table 5). Using the penetration of SRB and
RBHE into the corneocytes at z¼0 mm and z¼3 mm as a
marker for the existence of transcellular permeation pathways
in the stratum corneum, these results suggest that transcel-
lular permeation pathways are utilized in the delivery of SRB
and RBHE in the LTRs in both US-treated and US/SLS-treated
skin as well as in the delivery of SRB in SLS-treated skin. This
observation independently confirms that transcellular path-
ways are utilized by hydrophilic (and hydrophobic) per-
meants in the LTRs of US/SLS-treated skin, as proposed
recently based on a macroscopic analysis of the skin
electrical resistivity data in the context of the aqueous-pore
pathway hypothesis (Kushner et al., 2004).
Proposed mechanisms of enhancement in SLS-, US-, and US/
SLS-treated skin
As shown in the previous section, SLS increased the
partitioning of SRB into the corneocyte domain and in-
creased the localization of RBHE into the intercellular
domain. To achieve these observed results, SLS could
either increase the hydrophilicity of the corneocyte
domain or increase the hydrophobicity of the intercellular
domain. There is ample evidence that SLS increases the
hydration (i.e., water uptake) of the stratum corneum
(Miyazawa et al., 1984; Rhein et al., 1986; Wilhelm et al.,
1993; Goffin et al., 1999; Mizushima et al., 2000), as well as
some recent evidence that these hydration effects are
localized primarily in the corneocyte domain (Bouwstra
et al., 2003; Uhoda et al., 2005; Xhauflaire-Uhoda et al.,
2006). Therefore, SLS-induced absorption of water in the
corneocytes, which would increase the hydrophilicity of the
corneocyte domain, is a possible mechanism for the observed
results for the delivery of SRB and RBHE in SLS-treated skin
relative to untreated skin.
From previous studies of US-enhanced transdermal drug
delivery, it has been demonstrated that transient acoustic
cavitation events near the skin surface are the primary
mechanism responsible for the observed enhancement of
transdermal transport (Tang et al., 2002b; Tezel et al., 2002b;
Tezel and Mitragotri, 2003). In the present investigation, SRB
delivery was enhanced only in discrete regions of US-treated
skin (i.e., the highly permeable LTRs; Kushner et al., 2004)
relative to SRB delivery in untreated skin, similar to calcein
delivery in US-treated skin (Alvarez-Roma´n et al., 2003). This
result suggests that the transient acoustic cavitation events
form during US treatment occur in discrete regions, rather
than homogeneously, in the acoustic coupling medium near
the skin surface. When a transient cavitation bubble implodes
near the skin surface, high-velocity microjets are formed and
directed toward the surface of the skin (Tang et al., 2002b).
Because the corneocytes represent over 99% of the skin
surface, it is highly probable that these high-velocity
microjets deliver the probe-containing coupling medium into
the corneocytes near the skin surface forming the observed
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transcellular pathways in the LTRs and facilitating delivery of
the probe into the viable epidermis.
When a chemical enhancer (i.e., ethanol or SLS) is present
in the coupling medium during US treatment, the delivery of
SRB and RBHE in the non-LTRs also increases relative to the
delivery of SRB and RBHE in untreated skin. Because the
penetration of SRB and RBHE within the non-LTRs did not
extend into the corneocytes or the viable epidermis as it did
within the LTRs, it is likely that the chemical enhancer is not
inducing transient acoustic caviation events in the coupling
medium above the surface of the non-LTRs during US
treatment. Rather, acoustic streaming in the coupling
medium, another effect of US treatment of the skin (Wells,
1977), provides additional convective driving forces, which
may enhance the delivery and the dispersion of the chemical
enhancer (Mitragotri et al., 2000) into the non-LTRs. Once
the chemical enhancer penetrates into the skin, it may
enhance the transdermal delivery of SRB and RBHE by (i)
disordering the intercellular lipid bilayers (Fartasch et al.,
1998), (ii) disrupting the corneocyte cornified envelope
(Welzel et al., 1998), (iii) extracting lipids from the stratum
corneum (Elias, 1996; Alvarez-Roma´n et al., 2003), or (iv)
expanding and increasing the connectivity of the lacunar
domains present in the intercellular regions of the stratum
corneum (Paliwal et al., 2006).
MATERIALS AND METHODS
Chemicals
Phosphate-buffered saline (PBS; 0.01 M phosphate, 0.137 M NaCl)
was obtained from Fluka Chemical (St Louis, MO). SRB, a
hydrophilic fluorescent probe, and RBHE, a hydrophobic fluorescent
probe were obtained from Molecular Probes (Eugene, OR). Ethanol
and SLS were obtained from Sigma Chemical Company (St Louis,
MO). All these chemicals were used as received.
Skin preparation
All experimental protocols with human tissue were approved by the
Committee on the Use of Human Experimental Subjects (COUHES)
at MIT and were deemed to be in accordance with the guidelines
published in the Declaration of Helsinki Principles. Human full-
thickness skin samples from the abdominal area were obtained from
the National Disease Research Institute (Philadelphia, PA) and stored
at 801C for up to 3 months before use. Before its use in the
fluorescent permeant diffusion experiments (see below), the skin was
thawed and the subcutaneous fat was removed from the skin using a
razor blade. The skin was then sectioned and mounted in vertical
Franz diffusion cells (15-mm inner diameter) obtained from
Permegear (Bethlehem, PA). Finally, the initial electrical resistivity
of the skin was measured using previously published methods (Tang
et al., 2002a). Any skin sample with an initial resistivity lower than
50 kO/cm2, which is indicative of the skin sample being compro-
mised (Tang et al., 2002a), was discarded and replaced with a new
skin sample.
Preparation of the fluorescent permeant solutions
For the visualization of SRB in human skin, the following solutions
were prepared: Formulation (S-1), 0.05 mg/ml of SRB in PBS;
Formulation (S-2), 0.005 mg/ml of SRB in PBS; Formulation (S-3),
0.005 mg/ml of SRB in PBS containing 1% (w/v) SLS. For the
visualization of RBHE in human skin, the following solutions were
prepared: Formulation (R-1), 0.05 mg/ml of RBHE in a 50/50 mixture
of PBS and ethanol; Formulation (R-2), 0.005 mg/ml of RBHE in a
50/50 mixture of PBS and ethanol; Formulation (R-3), 0.005 mg/ml of
SRB in a 50/50 mixture of PBS and ethanol containing 1% (w/v) SLS.
The concentrations of SRB and RBHE in formulations S-1 to S-3 and
R-1 to R-3 were selected for the following reasons. For the enhanced
delivery of SRB and RBHE in the skin, a smaller concentration of
0.005 mg/ml was chosen to enable the detection of both the
fluorescent permeant and the intrinsic skin autofluorescence signals
(Yu et al., 2003b). For the delivery of SRB and RBHE in untreated
skin, a larger concentration of 0.05 mg/ml was chosen to ensure that
enough fluorescent permeant was present in the skin to be detected
with TPM. Ethanol was included in the RBHE solution to enable
solubility of RBHE, which is immiscible in PBS due to its relatively
high level of hydrophobicity (see Table 1). Finally, 1% (w/v) SLS was
selected as the amount of chemical enhancer to be consistent with
previous studies on LTRs using low-frequency sonophoresis (Kushner
et al., 2004).
Diffusion experiments using fluorescent permeants
Skin samples were divided into four groups: (1) untreated, (2) SLS-
treated (chemical enhancer only), (3) US-treated (low-frequency
sonophoresis only), and (4) US/SLS-treated (simultaneous application
of low-frequency US and a chemical enhancer). For the delivery of SRB
and RBHE in untreated skin samples, the skin was exposed to
Formulation (S-1) and to Formulation (R-1), respectively, for 24 hours.
For the delivery of SRB and RBHE in chemically enhanced skin
samples, the skin was exposed to Formulation (S-3) and to Formulation
(R-3), respectively, for 24 hours. For the delivery of SRB and RBHE in
US-treated skin samples, the skin was exposed to Formulation (S-2) and
to Formulation (R-2), respectively, for 24 hours in the presence of US at
the following conditions: frequency, 20 kHz; intensity, 1.6 W/cm2; duty
cycle, 0.1:0.9 seconds (ON:OFF); tip displacement, 3 mm. At the end of
the 24-hour exposure period, the skin electrical resistivity was
measured to determine the extent to which each delivery method
had perturbed the structure of the skin. For the delivery of SRB and
RBHE in skin samples treated simultaneously with low-frequency US
and a chemical enhancer (SLS), the skin was exposed to Formulation
(S-3) and to Formulation (R-3), respectively, in the presence of US at the
following conditions: frequency, 20 kHz; intensity, 7.5 W/cm2; duty
cycle, 5:5 seconds (ON:OFF); tip displacement, 3 mm, until the skin
electrical current reached a value of 225mA, similar to the conditions
examined previously for the study of LTR formation in skin treated
simultaneously with low-frequency US and a chemical enhancer
(Kushner et al., 2004). Note that this level of skin electrical current was
obtained after treating the skin simultaneously with US and SLS for
5–10 minutes.
Preparation of skin samples for TPM imaging
After delivery of SRB and RBHE into the skin, the skin samples were
removed from the Franz diffusion cells, and excess formulation was
removed from the skin surface by gently blotting the skin surface
with a Kimwipe (Kimberly-Clark Corporation, Roswell, GA). The
circular region of the skin exposed to the fluorescent permeants was
removed using a razor blade. A few drops of PBS were then added to
an imaging chamber (2.5 mm Coverwell; Grace Bio Labs, Bend, OR)
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covered with a No. 1, 22 mm 22 mm glass coverslip (VWR
Scientific, Media, PA) to ensure good contact of the skin surface
with the coverslip. The skin was then inserted into the imaging
chamber and subsequently mounted onto a glass microscope slide
(VWR Microslides, 25 75 mm).
Dual-channel TPM imaging and data collection
Dual-channel TPM imaging of the skin samples was conducted
according to previously published methods (Yu et al., 2003b), which
are briefly summarized here. The laser source was provided by a
femtosecond ti-sa laser (Tsunami, Spectra-Physics, Mountain View,
CA) pumped by a 5W diode-pumped, solid state CW laser (Millenia
V, Spectra-Physics, Mountain View, CA). For all the dual-channel
TPM imaging, the laser power was set at 250 mW to ensure detection
of the skin autofluorescence signal, while minimizing damage to the
skin from the laser. A modified inverted microscope (Axiovert,
100TV, Ziess, Thornwood, NY) with an oil immersion  40
objective lens (Zeiss F Fluar, NA.13) was used to image the skin
samples. X–Y scans were made with a scanner unit (6350 Cambridge
Technology, Watertown, MA). The emitted photons from the laser
excitation are collected by the microscope and then passed through
two filters, which split the signal into the red channel for the photons
emitted by the fluorescent permeant and the green channel for the
photons emitted by the intrinsic skin fluorophores. Splitting of
the signal into two channels is possible due to the differences in the
fluorescence emission wavelength of the intrinsic skin fluorophores
(450 and 520 nm) (Na et al., 2000) and the emission wavelengths of
SRB and RBHE (see Table 1). The signals from the red and the green
channels are then sent to a photomultiplier and are discriminated
against dark noise with a custom-built high-speed photon discrimi-
nator to obtain the final dual-channel TPM image. In untreated and
in SLS-treated skin, six 120 120 mm skin sites were imaged. In
US-treated and in US/SLS-treated skin, 12 120 120 mm skin sites
were imaged – six sites for the non-LTRs and six sites for the LTRs.
The depth of the TPM imaging varied from a depth of 40 mm, for skin
samples where little to no fluorescent permeant penetrated deep into
the skin, to a depth of 70 mm, for skin samples where significant
fluorescent permeant penetrated deep into the skin.
Analysis of the TPM images
The techniques that were used to analyze the dual-channel TPM
images of both SRB and RBHE are based on previously published
methods (Yu et al., 2001, 2003b), which are described briefly in this
section. These techniques include: (1) generating and analyzing the
average fluorescence intensity profiles for each permeant as a
function of skin depth, (2) evaluating the enhancement of the
fluorescent permeant vehicle-to-skin partition coefficient, (3) eval-
uating the enhancement of the fluorescent permeant intensity
gradient, (4) evaluating the enhancement of the effective diffusion
path length, and (5) evaluating the existence of transcellular
permeation pathways in the stratum corneum. All the TPM image
processing reported in this section was carried out using MATLAB
with the Image Processing Toolbox (Version 7.0.4.365 (R14) Service
Pack 2, The Mathworks Inc., Natick, MA).
The average fluorescent permeant intensity profiles as a function
of skin depth were generated using an in-lab subroutine in MATLAB,
which calculated an average value for the fluorescence intensity, I,
(obtained from photons collected during a time of 0.1 ms) for each
layer of the skin imaged in the z-direction (the direction perpendi-
cular to the skin surface). The surface of each skin sample,
corresponding to z¼ 0 mm, was defined at the location of the first
local maximum in the average value of the intensity of the
fluorescent probes as a function of increasing skin depth (Yu et al.,
2001). The average value of the fluorescence intensity at z¼ 0 mm
was then averaged over the 5–7 skin sites imaged for each of the six
types of skin samples examined in this study for the delivery of SRB
and RBHE: (1) untreated skin, (2) SLS-treated skin, (3) the non-LTRs
of US-treated skin, (4) the LTRs of US-treated skin, (5) the non-LTRs
of US/SLS-treated skin, and (6) the LTRs of US/SLS-treated skin. For
the average fluorescence intensity profiles of SRB and RBHE in
untreated skin, the value of I was divided by 10 to account for the
difference in the donor concentration of the fluorescent permeant
used for the untreated skin samples (0.05 mg/ml) and for the
enhanced skin samples (0.005 mg/ml). To determine whether
treatment of the skin with SLS, US, or US/SLS results in a significant
enhancement in the skin penetration of SRB and RBHE, the average
value of the fluorescent permeant intensity in the enhanced skin
samples and in the untreated skin samples were analyzed with the t-
statistic (Montgomery et al., 1998), which tests for the difference in
two average values where the variances are not equal, over the
depth of skin imaged. A value of P¼ 0.05, corresponding to a 95%
confidence interval, was selected for the analysis of the average
fluorescent permeant intensity profiles in this study.
The values for EK, EG, and EL, the enhancement in the vehicle-to-
skin partition coefficient, the intensity gradient, and the effective
diffusion path length, respectively, were obtained using previously
published methods (Yu et al., 2001), which are summarized briefly
here (Yu et al., 2001). By assuming that the intensity of the
fluorescent permeant, I, is directly proportional to its concentration
in the skin, EK can be approximated from the average fluorescence
intensity profiles using the following equation (Yu et al., 2001):
EK ¼ IEnhancerðz ¼ 0Þ
IUntreatedðz ¼ 0Þ
ð1Þ
where IEnhancer(z¼ 0) is the average value of the fluorescence
intensity of SRB or of RBHE at the surface of the enhanced skin
samples (i.e., SLS-, US-, or US/SLS-treated skin samples) and
IUntreated(z¼ 0) is the average value of the fluorescence intensity of
SRB or of RBHE at the surface of the untreated skin samples. The
fluorescent permeant intensity gradient, (dI/dz), in the stratum
corneum was evaluated by performing linear regression using the
average intensity values from the first 12 scans from the surface into
the stratum corneum, a region which exhibits a significant decrease
in the average fluorescent probe intensity in the untreated skin, to
which the average fluorescent probe intensities in the enhanced skin
samples are then compared (Yu et al., 2001). To calculate the
enhancement in the fluorescent permeant intensity gradient, EG, the
following equation was used (Yu et al., 2001):
EG ¼ ðdI=dzÞEnhancedðdI=dzÞUntreated
ð2Þ
where (dI/dz)Enhanced and (dI/dz)Untreated are the fluorescent permeant
intensity gradients corresponding to the intensity profiles of the
enhanced skin samples and of the untreated skin samples,
respectively. The enhancement in the effective diffusion path length,
EL, in enhanced skin samples as compared to untreated skin samples
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can then be evaluated from the values of EK and EG as follows
(Yu et al., 2001):
EL ¼ EK
EG
ð3Þ
The identification of transcellular pathways from an analysis of the
dual-channel TPM images is based on previously published methods
(Yu et al., 2003b). A slice, 5 pixels (width) 256 pixels (length), of
the red channel (probe) and of the green channel (skin auto-
fluorescence) TPM images was selected for analysis of the location of
the fluorescent permeant relative to the structure of the skin. At each
position along the length of this slice (0–255 pixels), the intensities of
the corresponding five pixels along the width were averaged and
then normalized. These normalized average values, for both the red
channel and the green channel, were plotted as a function of the
pixel number along the length of the slice. Previous studies utilizing
this dual-channel TPM image analysis technique have demonstrated
that it is possible to determine whether there is an increase, or a
decrease, in the penetration of the fluorescent probe into the
corneocytes (Yu et al., 2003b). Specifically, by measuring the widths
and the heights of peaks in the normalized average intensity profile
of the fluorescent probe in untreated skin, and subsequently
comparing these values to the peak widths and the peak heights of
the fluorescent probe in the enhanced skin samples, enhancements,
or reductions, in the penetration of the fluorescent probe into the
corneocytes can be evaluated quantitatively. As the heights of the
peaks increase and as the widths of the peaks decrease, there is less
fluorescent permeant present inside the corneocytes, which serves as
a qualitative indicator of the existence of intercellular permeation
pathways. Conversely, as the heights of the peaks decrease and as
the widths of the peaks increase, there is more fluorescent permeant
present inside the corneocytes, which serves as a qualitative
indicator of the existence of transcellular permeation pathways.
The height of a peak was determined by evaluating the difference
between the height of the peak and the average height of the two
valleys that neighbor the peak. The width of a peak was determined
by measuring the width of the peaks at half of the peak height. The
skin surface (z¼ 0mm) was selected as the skin layer to identify the
entries into the transcellular permeation pathways. The surface of the
skin is the first skin layer that is perturbed by SLS or by US, because it
is at the skin surface where the enhancing transient acoustic
cavitation events occur (Tang et al., 2002a, b; Tezel et al.,
2002a, b; Tezel and Mitragotri, 2003), and where the skin contacts
the coupling medium. For samples with transcellular pathway
entries present at z¼ 0 mm, additional measurements of the peak
heights and the peak widths were made at z¼ 3mm to demonstrate
that the transcellular pathways do indeed extend into the stratum
corneum. Note that this analysis was carried out to demonstrate the
existence of transcellular pathways in the stratum corneum, and does
not imply that these transcellular pathways extend only to a depth of
3mm.
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